CytoDyn Inc_INT sell geldnutzer
Start price
23.10.20
/
50%
€2.10
Target price
04.11.21
€1.00
Performance (%)
7.62%
End price
04.11.20
€2.26
Summary
This prediction ended on 04.11.20 with a price of €2.26. The SELL prediction by geldnutzer shows the price for CytoDyn Inc_INT slightly increased by 7.62% during the runtime of the prediction. geldnutzer has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
CytoDyn Inc_INT | - | - | - | - |
iShares Core DAX® | 0.347% | 2.173% | 18.599% | 21.611% |
iShares Nasdaq 100 | 0.715% | 0.138% | 26.542% | 40.349% |
iShares Nikkei 225® | 1.522% | 2.003% | 13.220% | 3.542% |
iShares S&P 500 | 0.631% | 1.633% | 25.009% | 42.942% |
According to geldnutzer what are the pros and cons of CytoDyn Inc_INT for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
Valuable balance sheet
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Very Future proof/growth oriented business model
Cons
Significant cyclical dependencies
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Little known brand
Comments by geldnutzer for this prediction
In the thread CytoDyn Inc diskutieren
Sell mit Kursziel 1,0
In the thread Trading CytoDyn Inc
Sell beendet
Stopped prediction by geldnutzer for CytoDyn Inc_INT
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€0.29
02.03.23
02.03.23
€0.10
02.03.24
02.03.24
-25.70%
03.03.24
03.03.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€0.33
27.02.23
27.02.23
€0.50
27.02.24
27.02.24
-10.72%
02.03.23
02.03.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€0.34
19.11.22
19.11.22
€0.10
19.11.23
19.11.23
-5.60%
27.02.23
27.02.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€0.65
21.07.22
21.07.22
€0.60
21.07.23
21.07.23
-46.97%
19.11.22
19.11.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€0.66
09.01.22
09.01.22
€0.20
09.01.23
09.01.23
-1.09%
21.07.22
21.07.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€0.88
20.12.21
20.12.21
€1.20
20.12.22
20.12.22
-25.64%
09.01.22
09.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€1.28
10.07.21
10.07.21
€0.80
10.07.22
10.07.22
-30.80%
20.12.21
20.12.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€2.26
04.11.20
04.11.20
€3.20
04.11.21
04.11.21
-43.45%
10.07.21
10.07.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies